Showing results (81-90 of 247) with videos related to
Sort By:
Pageof 25
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probabilityAla Yaromina, Lydia Koi, Lesley Schuitmaker, et al.Oncoimmunology|January 9, 2018
Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancerArmin Jarosch, Ulrich Sommer, Andreas Bogner, et al.Plos One|December 21, 2018
Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapyNils Cordes, Michael Ney, Thomas Beleites, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 2020
Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancerSebastian Zschaeck, Klaus Zöphel, Annekatrin Seidlitz, et al.Cancers|February 11, 2023
Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome PredictionSebastian Starke, Alexander Zwanenburg, Karoline Leger, et al.Radiation Research|April 23, 2019
Predicting <i>In Vitro</i> Cancer Cell Survival Based on Measurable Cell CharacteristicsHakan Oesten, Cläre von Neubeck, Aline Jakob, et al.European Urology|December 23, 2018
Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al.Medical Physics|February 11, 2020
Refinement of the Hounsfield look-up table by retrospective application of patient-specific direct proton stopping-power prediction from dual-energy CTPatrick Wohlfahrt, Christian Möhler, Wolfgang Enghardt, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 4, 2004
Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiationAndreas Schreiber, Mechthild Krause, Daniel Zips, et al.Cancers|June 21, 2020
Applying Tissue Slice Culture in Cancer Research-Insights from Preclinical Proton RadiotherapyTheresa Suckert, Treewut Rassamegevanon, Johannes Müller, et al.Pageof 25